# Novo Nordisk A/S (NOVO-B.CO): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Novo Nordisk A/S (NOVO-B.CO) is 89/100, ranked against 24,000+ stocks in 35 markets (Quality 75, Value 66, Momentum 49, each scored against its sector).

- StockRank: 89/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 75, Value 66, Momentum 49: each a 0-100 percentile within Healthcare.
- Position: #3,000 overall, #341 in Healthcare.
- Listing: Denmark, CPH; Healthcare / Drug Manufacturers - General.
- Last close: 260.15 DKK on 23 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.
- Buybacks, last 180 days: the company bought back USD 1.1B on 120 days.

Source: https://moatmap.ai/stock/NOVO-B.CO
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker